General Information
Revision date
2022-01-14
Product name
1 of 5
Substance name
Nalmefene hydrochloride
CAS No.
58895-64-0
REACH No
is
1.2.1 Relevant identified uses
other biochemicals
1.2.2. Uses advised against
not for food or drug use, for laboratory use only
Emergency telephone
+44 118 338 8269
Icons in SDS
Company Information
company name
Carbosynth Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
customerservice@biosynth-carbosynth.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H312, H317, H332, H334
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Physical hazards
not classified
Health hazards
Acute toxicity inhalation (Category 4), H332 Respiratory sensitiser (Category 1), H334 Acute toxicity dermal (Category 4), H312 Skin sensitiser (Category 1), H317 Acute toxicity oral (Category 4), H302
Environmental hazards
not classified
2.2 Label elements
Regulatory List EC1272/08 Regulation (EC)
Hazard pictograms
GHS07 exclamation mark GHS08
Signal word
Danger Danger
Hazard statements
H302 Harmful if swallowed. H312 Harmful in contact with skin. H317 May cause an allergic skin reaction. H332 Harmful if inhaled. H334 May cause allergy or asthma symptoms or breathingdifficulties if inhaled.
Precautionary statements
P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P270 Do no eat, drink or smoke when using this product. P280 Wear protective gloves/protective clothing/eye protection/face protection. P301+P312 IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell. P302+P352 IF ON SKIN: Wash with plenty of soap and water. P304+P340 IF INHALED: Remove casualty to fresh air and keepat rest in a position comfortable for breathing. P501 Dispose of contents / container in accordance with local / regional / national / international regulations.
2.3 Other hazards
Caution! To the best of our knowledge the toxicological properties of this material have not been thoroughly investigated.
